Enhancing the prediction of childhood asthma remission: Integrating clinical factors with microRNAs - 04/03/21
Doi : 10.1016/j.jaci.2020.08.019
Alberta L. Wang, MD, MS a, b 
, Jiang Li, PhD a, Alvin T. Kho, PhD a, Michael J. McGeachie, PhD a, Kelan G. Tantisira, MD, MPH a, c
, Jiang Li, PhD a, Alvin T. Kho, PhD a, Michael J. McGeachie, PhD a, Kelan G. Tantisira, MD, MPH a, c a Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, Mass
b Division of Allergy and Clinical Immunology, Brigham and Women’s Hospital, Boston, Mass
c Division of Pulmonary and Critical Care, Brigham and Women’s Hospital, Boston, Mass
| This study was supported by the National Institutes of Health (grant nos. R01 HL127332, R01 HL129935, and P01 HL132825) and Thrasher Research Fund (15115). |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 147 - N° 3
P. 1093 - Marzo 2021 Ritorno al numero
Articolo precedente
- Clearance of apoptotic cells by lung alveolar macrophages prevents development of house dust mite-induced asthmatic lung inflammation
- Haruka Miki, Hong Pei, Donald Tom Gracias, Joel Linden, Michael Croft
- A deoxyribonuclease 1–like 3 genetic variant associates with asthma exacerbations
- Esther Herrera-Luis, Fabian Lorenzo-Diaz, Lesly-Anne Samedy-Bates, Celeste Eng, Jesús Villar, Jose R. Rodriguez-Santana, Esteban G. Burchard, Maria Pino-Yanes
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?